TABLE 2.

Effect of treatment with N-methylglucamine antimoniate (28 mg Sb(v)/kg/day for 10 days) by subcutaneous route and eight 2-substituted quinolines (n = 8) (25 mg/kg/day for 10 days) administered orally in Leishmania infantum-infected BALB/c mice^e

^an = 18.

^bStatistically significant (P < 0.05) compared with meglumine antimoniate-treated mice.

^cStatistically significant (P < 0.001) compared with meglumine antimoniate-treated mice.

^dStatistically significant (P < 0.0001) compared with meglumine antimoniate-treated mice.

^eStatistical significance compared to untreated mice is indicated as follows: *, P < 0.05; **, P < 0.001; ***, P < 0.0001.